|
1
|
Peng YC, Lin CL, Hsu WY, Chang CS, Yeh HZ,
Liao SC and Kao CH: The risk of colorectal cancer is related to
frequent hospitalization of IBD in an Asian population: Results
from a nationwide study. QJM. 108:457–463. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hibino Y, Sakamoto N, Naito Y, Goto K, Oo
HZ, Sentani K, Hinoi T, Ohdan H, Oue N and Yasui W: Significance of
miR-148a in colorectal neoplasia: Downregulation of miR-148a
contributes to the carcinogenesis and cell invasion of colorectal
cancer. Pathobiology. 82:233–241. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Jass JR, Love SB and Northover JM: A new
prognostic classification of rectal cancer. Lancet. 1:1303–1306.
1987. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bartel DP: MicroRNAs: Target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Di Leva G and Croce CM: Roles of small
RNAs in tumor formation. Trends Mol Med. 16:257–267. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Doleshal M, Magotra AA, Choudhury B,
Cannon BD, Labourier E and Szafranska AE: Evaluation and validation
of total RNA extraction methods for microRNA expression analyses in
formalin-fixed, paraffin-embedded tissues. J Mol Diagn. 10:203–211.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Xiao R, Li C and Chai B: miRNA-144
suppresses proliferation and migration of colorectal cancer cells
through GSPT1. Biomed Pharmacother. 74:138–144. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yan L, Yao J and Qiu J: miRNA-495
suppresses proliferation and migration of colorectal cancer cells
by targeting FAM83D. Biomed Pharmacother. 96:974–981. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kim CW, Oh ET, Kim JM, Park JS, Lee DH,
Lee JS, Kim KK and Park HJ: Hypoxia-induced microRNA-590-5p
promotes colorectal cancer progression by modulating matrix
metalloproteinase activity. Cancer Lett. 416:31–41. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yan S, Jiang Y, Liang C, Jin C, Duan Q, Xu
D, Yang L, Zhang X, Ren B and Jin P: Exosomal miR-6803-5p as
potential diagnostic and prognostic marker in colorectal cancer. J
Cell Biochem. 119:4113–4119. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li Q, Ren P, Shi P, Chen Y, Xiang F, Zhang
L, Wang J, Lv Q and Xie M: MicroRNA-148a promotes apoptosis and
suppresses growth of breast cancer cells by targeting B-cell
lymphoma 2. Anticancer Drugs. 28:588–595. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Cao H, Liu Z, Wang R, Zhang X, Yi W, Nie
G, Yu Y, Wang G and Zhu M: miR-148a suppresses human renal cell
carcinoma malignancy by targeting AKT2. Oncol Rep. 37:147–154.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Dong P, Ihira K, Xiong Y, Watari H, Hanley
SJ, Yamada T, Hosaka M, Kudo M, Yue J and Sakuragi N: Reactivation
of epigenetically silenced miR-124 reverses the
epithelial-to-mesenchymal transition and inhibits invasion in
endometrial cancer cells via the direct repression of IQGAP1
expression. Oncotarget. 7:20260–20270. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Feng H, Wang Y, Su J, Liang H, Zhang CY,
Chen X and Yao W: MicroRNA-148a suppresses the proliferation and
migration of pancreatic cancer cells by down-regulating ErbB3.
Pancreas. 45:1263–1271. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Campbell MR, Amin D and Moasser MM: HER3
comes of age: new insights into its functions and role in
signaling, tumor biology, and cancer therapy. Clin Cancer Res.
16:1373–1383. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Guy PM, Platko JV, Cantley LC, Cerione RA
and Carraway KL III: Insect cell-expressed p180erbB3 possesses an
impaired tyrosine kinase activity. Proc Natl Acad Sci USA.
91:8132–8136. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sierke SL, Cheng K, Kim HH and Koland JG:
Biochemical characterization of the protein tyrosine kinase
homology domain of the ErbB3 (HER3) receptor protein. Biochem J.
322:757–763. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Jura N, Shan Y, Cao X, Shaw DE and Kuriyan
J: Structural analysis of the catalytically inactive kinase domain
of the human EGF receptor 3. Proc Natl Acad Sci USA.
106:21608–21613. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sithanandam G, Fornwald LW, Fields J and
Anderson LM: Inactivation of ErbB3 by siRNA promotes apoptosis and
attenuates growth and invasiveness of human lung adenocarcinoma
A549. Oncogene. 24:1847–1859. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Appert-Collin A, Hubert P, Crémel G and
Bennasroune A: Role of ErbB receptors in cancer cell migration and
invasion. Front Pharmacol. 6:2832015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yu J, Li Q, Xu Q, Liu L and Jiang B:
MiR-148a inhibits angiogenesis by targeting ERBB3. J Biomed Res.
25:170–177. 2011. View Article : Google Scholar : PubMed/NCBI
|
